Parallel Advisors, LLC Novo Cure LTD Transaction History
Parallel Advisors, LLC
- $4.18 Billion
- Q3 2024
A detailed history of Parallel Advisors, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Parallel Advisors, LLC holds 1,791 shares of NVCR stock, worth $49,162. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,791
Previous 1,863
3.86%
Holding current value
$49,162
Previous $31,000
12.9%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding NVCR
# of Institutions
262Shares Held
77MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$333 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$325 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$217 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$118 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$83.2 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.88B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...